BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11390455)

  • 21. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
    Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
    Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PPARgamma ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis.
    Hashimoto K; Ethridge RT; Saito H; Rajaraman S; Evers BM
    Pancreas; 2003 Jul; 27(1):58-66. PubMed ID: 12826907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome proliferator-activated receptor-γ and heme oxygenase-1 in rat hippocampal slices.
    Kim SE; Lee EO; Yang JH; Kang JH; Suh YH; Chong YH
    J Neurosci Res; 2012 Sep; 90(9):1732-42. PubMed ID: 22487967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
    Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X
    Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2.
    Garcia Palacios V; Morita I; Murota S
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):215-21. PubMed ID: 11728175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
    Bernardo A; Levi G; Minghetti L
    Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292).
    Chiba T; Ueki S; Ito W; Kato H; Takeda M; Kayaba H; Furue M; Chihara J
    Int Arch Allergy Immunol; 2009; 149 Suppl 1():77-82. PubMed ID: 19494510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock.
    Kaplan JM; Cook JA; Hake PW; O'Connor M; Burroughs TJ; Zingarelli B
    Shock; 2005 Jul; 24(1):59-65. PubMed ID: 15988322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma.
    Meier CA; Chicheportiche R; Juge-Aubry CE; Dreyer MG; Dayer JM
    Cytokine; 2002 Jun; 18(6):320-8. PubMed ID: 12160520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo.
    Thieringer R; Fenyk-Melody JE; Le Grand CB; Shelton BA; Detmers PA; Somers EP; Carbin L; Moller DE; Wright SD; Berger J
    J Immunol; 2000 Jan; 164(2):1046-54. PubMed ID: 10623855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
    Sinha D; Addya S; Murer E; Boden G
    Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation.
    Kobayashi Y; Ueki S; Mahemuti G; Chiba T; Oyamada H; Saito N; Kanda A; Kayaba H; Chihara J
    J Immunol; 2005 Nov; 175(9):5744-50. PubMed ID: 16237065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
    Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L
    J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
    Guyton K; Bond R; Reilly C; Gilkeson G; Halushka P; Cook J
    J Leukoc Biol; 2001 Apr; 69(4):631-8. PubMed ID: 11310850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.